Menu

Blog

Archive for the ‘biotech/medical’ category: Page 2611

Oct 6, 2016

Printing Skin Cells on Burn Wounds

Posted by in category: biotech/medical

In our project to “print” skin cells on burn wounds.we place cells in vials, rather than in cartridges, and “print” them through an ink jet printer head.

Read more

Oct 5, 2016

With New Program, DARPA To Encourage Safety “Brakes” For Gene Editing

Posted by in categories: bioengineering, biotech/medical, finance, genetics, health, military

Xconomy National —

Drugs that use molecular scissors to snip out or replace defective genes. Altered mosquitoes meant to sabotage entire disease-carrying populations. Both are potential uses of genome editing, which thanks to the CRISPR-Cas9 system has spread throughout the world’s biology labs and is now on the doorstep of the outside world. But with its first applications could also come unintended consequences for human health and the environment. The U.S. Defense Advanced Research Projects Agency—a famed military R&D group—wants to finance safety measures for the new gene-editing age.

The idea for the funding program, called Safe Genes, is to get out ahead of problems that could bring the field to a screeching halt. “We should couple innovation with biosecurity,” DARPA program manager Renee Wegrzyn, said Tuesday at the SynBioBeta conference in South San Francisco. “We need new safety measures that don’t slow us down. You have brakes in your car so that you can go fast but can stop when you need to.”

Continue reading “With New Program, DARPA To Encourage Safety ‘Brakes’ For Gene Editing” »

Oct 5, 2016

Did Raquel Welch inspire Nobel Prize winner’s nano vehicle?

Posted by in categories: biotech/medical, nanotechnology

You really have to wonder sometimes.


THE futuristic world depicted in the classic science-fiction film Fantastic Voyage, starring Raquel Welch in a very clingy catsuit, could very soon be a reality as scientists have discovered a way of shrinking vehicles that could be placed inside the human body.

Read more

Oct 5, 2016

Nobel Prize in chemistry goes to designers of molecular motors

Posted by in categories: biotech/medical, chemistry, nanotechnology, robotics/AI

The Nobel Prize in chemistry was awarded on Wednesday to scientists based in the US, France, and the Netherlands for breakthroughs in designing molecular machines that can carry out tasks— and even mimic a four-wheel-drive car — when given a jolt of energy.

Winners J. Fraser Stoddart, Jean-Pierre Sauvage, and Bernard L. Feringa discovered how to build tiny motors — 1,000 times thinner than a strand of hair.

The machinery includes rings on axles, spinning blades, and even unimaginably small creations consisting of only a few molecules that can lift themselves off a surface like tiny robots rising on tip-toe. Those molecular robots can pluck, grasp, and connect individual amino acids. The machines can also be used as a novel mechanism of drug delivery.

Read more

Oct 5, 2016

Robot surgeons and artificial life: the promise of tiny machines

Posted by in categories: biotech/medical, chemistry, nanotechnology, robotics/AI

What are the potential uses for molecular machines, which have won the 2016 Nobel Prize in Chemistry.

Read more

Oct 5, 2016

(Im)mortality: Researchers Find That Human Lifespan Has A Max Limit

Posted by in categories: bioengineering, biotech/medical, life extension

In Brief.

  • New research concludes that human lifespan has already reached its peak of 125 years.
  • The research does not take into account synthetic biology and advancements in biotech that could extend lifespans further.

Scientists at the Albert Einstein College of Medicine assert that they have discovered the maximum lifespan of human beings, and it’s a range we may no longer be able to exceed. Dr. Jan Vijg, professor of ophthalmology and visual sciences at Einstein, lead the research, which was published online today in the journal Nature.

Read more

Oct 5, 2016

An Example of the Glaring Lack of Ambition in Aging Research

Posted by in categories: biotech/medical, life extension

Scientific progress is being held back by established experts who lack ambition and vision.


The mainstream of aging research, at least in public, is characterized by a profound lack of ambition when it comes to treating aging as a medical condition. Researchers talk about slightly altering the trajectory of aging as though that is the absolute most that is possible, the summit of the mountain, and are in many cases ambivalent when it comes to advocating for even that minimal goal. It is this state of affairs that drove Aubrey de Grey and others into taking up advocacy and research, given that there are clear paths ahead to rejuvenation, not just a slight slowing of aging, but halting and reversing the causes of aging. Arguably embracing rejuvenation research programs would in addition cost less and take a much shorter span of time to produce results, since these programs are far more comprehensively mapped out than are efforts to produce drugs to alter the complex operations of metabolism so as to slightly slow the pace at which aging progresses. It is most frustrating to live in a world in which this possibility exists, yet is still a minority concern in the research community. This article is an example of the problem, in which an eminent researcher in the field takes a look at a few recently published books on aging research, and along the way reveals much about his own views on aging as an aspect of the human condition that needs little in the way of a solution. It is a terrible thing that people of this ilk are running the institutes and the funding bodies: this is a field crying out for disruption and revolution in the name of faster progress towards an end to aging.

Quote:

Continue reading “An Example of the Glaring Lack of Ambition in Aging Research” »

Oct 5, 2016

Wisdom teeth being saved for stem cell use

Posted by in category: biotech/medical

Finally a better ROI than selling them to the tooth fairy!


HOUSTON — A lot of research has been done on the benefits of saving stem cells from a baby’s umbilical cord, but not all parents realize the same cells can be taken from a child’s tooth that falls out or from a wisdom tooth.

A couple of weeks ago, 19-year-old Sydney Addicks had her wisdom teeth removed and saved in case of an emergency.

Continue reading “Wisdom teeth being saved for stem cell use” »

Oct 5, 2016

It is time to classify biological aging as a disease

Posted by in categories: biotech/medical, health, life extension, neuroscience

Classifying aging as a disease, the debate is hotting up as ICD11 at WHO draws near.


What is considered to be normal and what is considered to be diseased is strongly influenced by historical context (Moody, ). Matters once considered to be diseases are no longer classified as such. For example, when black slaves ran away from plantations they were labeled to suffer from drapetomania and medical treatment was used to try to “cure” them (Reznek, ). Similarly, masturbation was seen as a disease and treated with treatments such as cutting away the clitoris or cauterizing it (Reznek, ). Finally, homosexuality was considered a disease as recently as 1974 (Reznek, ). In addition to the social and cultural influence on disease definition, new scientific and medical discoveries lead to the revision of what is a disease and what is not (Butler, ). For example, fever was once seen as a disease in its own right but the realization that different underlying causes would lead to the appearance of fever changed its status from disease to symptom (Reznek, ). Conversely, several currently recognized diseases, such as osteoporosis, isolated systolic hypertension, and senile Alzheimer’s disease, were in the past ascribed to normal aging (Izaks and Westendorp, ; Gems, ). Osteoporosis was only officially recognized as a disease in 1994 by the World Health Organization (WHO, ).

Continue reading “It is time to classify biological aging as a disease” »

Oct 5, 2016

How we can profit from winning the battle against ageing

Posted by in categories: biotech/medical, health, life extension

How society can profit from treating age-related diseases.


We’re now living longer than ever – only to suffer from diseases of old age. New therapies promise a new lease of life for the elderly – and big profits for investors, says Matthew Partridge.

Over the past century, average life expectancy in most countries has grown substantially. Vastly lower infant mortality, improved living standards, better public sanitation, and the discovery of cures or vaccines for many once-deadly diseases, have seen average life expectancy in most developed nations rise to around 80, compared with 50 in 1900. Developing nations have benefited too. Life expectancy in China, for example, was just 43 in 1960 – it’s 75 today. Indeed, according to the World Health Organisation, no individual nation outside Africa now has a life expectancy of below 60, and even Africa has seen huge gains since 2000, helped by improved anti-malarial measures and wider availability of HIV/Aids treatments.

Continue reading “How we can profit from winning the battle against ageing” »